Clinical trials in Craiova – page 11

322 clinical trials in Craiova, Romania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in RomaniaStudii.Clinice.ro

Craiova at a glance

322

clinical trials

Research sites3

Quick filters

322 trials in Craiova

Open in trial search

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Type 2 diabetes mellitus+2

Not yet recruiting

Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

Investigational

Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

Investigational

Romania

Participants:18–64 years · 65+ years
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Asthma

Not yet recruiting

Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

Registered drugNo placebo

Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Beclometasone Dipropionate
Sponsor:Chiesi Farmaceutici S.p.A.

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Study of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors

Registered drugNo placebo

Study of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:Immunitybio Inc.

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Romania

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Psoriasis

Not yet recruiting

Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

Registered drug

Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Deucravacitinib
Sponsor:Janssen Cilag International

Contact Research Centre

Rheumatoid arthritis

Not yet recruiting

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Tocilizumab
Sponsor:Dr Reddy's Laboratories Limited

Contact Research Centre

Anaemia+1

Not yet recruiting

Study of Elritercept (TAK‑226) with Ruxolitinib vs Placebo in Patients with Myelofibrosis and Anemia on Ruxolitinib Therapy

Registered drug

Study of Elritercept (TAK‑226) with Ruxolitinib vs Placebo in Patients with Myelofibrosis and Anemia on Ruxolitinib Therapy

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Elritercept
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Atrial fibrillation

Not yet recruiting

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Investigational

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:REGN7508
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Clear cell renal cell carcinoma+2

Not yet recruiting

Phase 1/2 Study of pumitamig Alone or Combined with ipilimumab or cabozantinib in Patients with Advanced Renal Cell Carcinoma

Registered drugNo placebo

Phase 1/2 Study of pumitamig Alone or Combined with ipilimumab or cabozantinib in Patients with Advanced Renal Cell Carcinoma

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Cabozantinib
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Idiopathic pulmonary fibrosis

Not yet recruiting

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Registered drugNo placebo

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Deupirfenidone
Sponsor:Puretech Lyt 100 Inc.

Contact Research Centre

Asthma

Not yet recruiting

Long‑Term Safety and Tolerability Study of Oral KT‑621 in Adults with Uncontrolled Moderate‑to‑Severe Eosinophilic Asthma

InvestigationalNo placebo

Long‑Term Safety and Tolerability Study of Oral KT‑621 in Adults with Uncontrolled Moderate‑to‑Severe Eosinophilic Asthma

InvestigationalNo placebo

Romania

Participants:18–64 years · 65+ years
Sponsor:Kymera Therapeutics Inc.

Contact Research Centre

Other cities in Romania

The busiest research cities in the country

All 65 cities in Romania

Clinical research in Craiova

What the registry says about research in the country

01 Respiratory Medicine

Current trials focus on innovative treatments for pulmonary conditions, including investigations into new therapies for asthma and pulmonary fibrosis. Research evaluates medication effectiveness in improving lung function and breathing capacity.

Idiopathic Pulmonary Fibrosis
Uncontrolled Asthma
Non-small Cell Lung Cancer

Studies incorporate both targeted therapies and combination treatments to address various stages of respiratory diseases.

02 Oncology

Groundbreaking research in cancer treatment explores novel therapeutic approaches for various types of cancer, with particular focus on gastric, prostate, and lung cancers.

Metastatic Gastric Cancer
Prostate Cancer
Head and Neck Cancer
Breast Cancer

Trials evaluate combination therapies and immunotherapy approaches for improved patient outcomes.

03 Cardiovascular and Metabolic

Studies focus on preventing and treating heart failure and related conditions, with innovative approaches to cardiovascular disease management and metabolic disorders.

Heart Failure Prevention
Chronic Kidney Disease
Cardiovascular Disease
Weight Management

Research emphasizes both preventive strategies and treatment interventions for cardiovascular conditions.

04 Immunology

Advanced research in autoimmune conditions and inflammatory disorders, investigating new therapeutic options for various immune-mediated diseases.

Plaque Psoriasis
Psoriatic Arthritis
Chronic Immune Thrombocytopenia
Chronic Rhinosinusitis

Studies evaluate both targeted therapies and broader immunological approaches.

05 Neurology and Mental Health

Innovative research addressing neurological disorders and mental health conditions, with focus on both therapeutic interventions and disease management.

Alzheimer's Disease Psychosis
Major Depressive Disorder

Trials explore novel treatment approaches for complex neurological and psychiatric conditions.

Back to Romania All countries